Multimerization of TREM2 is impaired by Alzheimer's disease–associated variants
Alzheimer's & Dementia · 2024-09 · 20 (9) · 6332-6350
DOI: 10.1002/alz.14124 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 20.07.2024. Verfasst von Hunter B Dean und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, School of Engineering, University of Alabama at Birmingham, Birmingham, Alabama, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Membrane Glycoproteins, Receptors, Immunologic. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NIA NIH HHS, BrightFocus Foundation.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION The immune receptor triggering receptor expressed on myeloid cells 2 (TREM2) is among the strongest genetic risk factors for Alzheimer's disease (AD) and is a therapeutic target. TREM2 multimers have been identified in crystallography and implicated in the efficacy of antibody therapeutics; however, the molecular basis for TREM2 multimerization remains poorly understood. METHODS We used molecular dynamics simulations and binding energy analysis to determine the effects of AD‐associated variants on TREM2 multimerization and validated with experimental results. RESULTS TREM2 trimers remained stably bound, driven primarily by salt bridge between residues D87 and R76 at the interface of TREM2 units. This salt bridge was disrupted by the AD‐associated variants R47H and R98W and nearly ablated by the D87N variant. This decreased binding among TREM2 multimers was validated with co‐immunoprecipitation assays. DISCUSSION This study uncovers a molecular basis for TREM2 forming stable trimers and unveils a novel mechanism by which TREM2 variants may increase AD risk by disrupting TREM2 oligomerization to impair TREM2 normal function. Highlights Triggering receptor expressed on myeloid cells 2 (TREM2) multimerization could regulate TREM2 activation and function. D87–R76 salt bridges at the interface of TREM2 units drive the formation of stable TREM2 dimers and trimers. Alzheimer's disease (AD)–associated R47H and R98W variants disrupt the D87–R76 salt bridge. The AD‐associated D87N variant leads to complete loss of the D87–R76 salt bridge.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, School of Engineering, University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Alzheimer's Disease Center, Center for Neurodegeneration and Experimental Therapeutics, & Departments of Neurology and Neurobiology, Marnix E. Heersink School of Medicine, University of Alabama at Birmingham, Birmingham…
- Medical Scientist Training Program, Marnix E. Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Department of Biochemistry and Molecular Biophysics, Hope Center for Neurological Disorders, & Department of Cell Biology and Physiology…
ORCID-Profile: Yuhua Song
Förderung
- NIH HHS
- NIA NIH HHS
- BrightFocus Foundation
- Alzheimer's of Central Alabama
- Alabama Innovation Fund
- Alzheimer's Association
- NINDS NIH HHS
- National Science Foundation
Zitieren
APA
Dean, H. B., Greer, R. A., Yang, S. Z., Elston, D. S., Brett, T. J., Roberson, E. D., & Song, Y. (2024). Multimerization of TREM2 is impaired by Alzheimer's disease–associated variants. Alzheimer's & Dementia, 20(9), 6332-6350. https://doi.org/10.1002/alz.14124
Vancouver
Dean HB, Greer RA, Yang SZ, Elston DS, Brett TJ, Roberson ED, et al. Multimerization of TREM2 is impaired by Alzheimer's disease–associated variants. Alzheimer's & Dementia. 2024;20(9):6332-6350. doi:10.1002/alz.14124
BibTeX
@article{Dean2024,
author = {Dean, Hunter B and Greer, Rory A and Yang, Shan-Zhong and Elston, Daniel S and Brett, Thomas J and Roberson, Erik D and Song, Yuhua},
title = {Multimerization of TREM2 is impaired by Alzheimer's disease–associated variants},
journal = {Alzheimer's & Dementia},
year = {2024},
volume = {20},
number = {9},
pages = {6332--6350},
doi = {10.1002/alz.14124}
}
EUVIMED